Medicaid rarely covers hair loss treatment. Most state Medicaid programs classify hair loss as a cosmetic concern, which means the vast majority of treatments, from prescription medications to hair transplants, fall outside standard coverage. The exceptions are narrow: if your hair loss stems from a specific medical condition like alopecia areata or scarring alopecia caused by lupus, some coverage may apply, but even then it depends heavily on your state and your specific plan.
Why Most Hair Loss Treatment Is Excluded
Medicaid programs distinguish between cosmetic and medically necessary care. Pattern baldness, the most common type of hair loss in both men and women, is considered cosmetic. That means treatments aimed at regrowing or restoring hair for this condition are not covered in any state.
This exclusion extends to some surprising areas. The two most well-known hair loss medications, minoxidil and finasteride, do appear on some state Medicaid formularies, but not for hair loss. Michigan’s Medicaid formulary, for example, lists minoxidil as a blood pressure medication and finasteride as a prostate treatment. If your doctor prescribes either drug for its original approved purpose, Medicaid may cover it. But prescribing these same drugs specifically for hair regrowth is considered off-label cosmetic use, and Medicaid programs generally exclude cosmetic-purpose medications.
Conditions That May Qualify for Coverage
Two categories of hair loss are sometimes considered medically appropriate for treatment: alopecia areata (an autoimmune condition where the immune system attacks hair follicles) and scarring alopecia caused by conditions like discoid lupus or lichen planus. These are the only diagnoses that typically cross the threshold from cosmetic to medical in insurance policy language.
Even with a qualifying diagnosis, coverage is contract-dependent. That phrase appears repeatedly in insurer medical policies and essentially means your specific Medicaid plan must include a benefit for that service. Having alopecia areata does not automatically unlock treatment coverage. You still need your plan to recognize the benefit, your provider to document medical necessity, and often prior authorization before treatment begins.
For alopecia areata specifically, newer FDA-approved treatments called JAK inhibitors have shown real promise. But a recent analysis of state Medicaid formularies found that virtually no state directly covered these medications. California was the sole exception, covering one JAK inhibitor (baricitinib). Many other states either required prior authorization or simply did not list these drugs at all. This creates a frustrating gap where effective, FDA-approved treatments exist but remain financially out of reach for Medicaid enrollees.
Hair Transplants Are Not Covered
Surgical hair restoration is categorically excluded. Medical policies that address hair loss explicitly state that hair transplants are considered not medically necessary, regardless of the underlying cause. Even patients with scarring alopecia from lupus or burns cannot get Medicaid to pay for transplant surgery. This applies across commercial and Medicaid plans alike.
Wigs and Cranial Prostheses
For many people dealing with significant hair loss, whether from chemotherapy, alopecia areata, or autoimmune conditions, wigs or cranial prostheses serve as a practical coping strategy. Up to 47 percent of people with alopecia report anxiety and depression, and hair prosthetics can meaningfully improve quality of life.
Despite this, Medicaid does not cover wigs in any state. There is a medical billing code (A9282) that classifies wigs as durable medical equipment, and some private insurers do reimburse for cranial prostheses with a doctor’s prescription. But state Medicaid programs have not adopted this coverage. Legislative efforts like the proposed Alopecia Areata Medicaid Improvement and Parity Act have attempted to change this, but none have passed into law.
This gap hits certain populations harder than others. Black women are disproportionately affected by conditions causing hair loss, including alopecia areata and central centrifugal cicatricial alopecia, and are also more likely to rely on Medicaid for their health coverage.
Scalp Cooling During Chemotherapy
Scalp cooling devices, which reduce blood flow to hair follicles during chemotherapy to prevent hair loss, have been recognized as reasonable and necessary for patients with solid tumors. FDA-cleared scalp cooling systems are the key distinction here: devices that have FDA clearance can be considered medically appropriate, while unregulated alternatives are not.
However, this recognition comes primarily from Medicare coverage determinations. Whether your state Medicaid program covers scalp cooling is a separate question, and most have not issued clear policies on it. If you are undergoing chemotherapy and want to explore scalp cooling, ask your oncology team whether your specific Medicaid plan includes this benefit. Some cancer centers also have financial assistance programs that can help cover the cost independently of insurance.
How to Check Your State’s Policy
Because Medicaid is administered at the state level, coverage rules vary significantly from one state to the next. California’s Medi-Cal program, for instance, covers at least one newer alopecia medication that no other state Medicaid program does. What applies in one state may not apply in yours.
To find out what your plan covers, start with your Medicaid managed care plan’s member services number (on the back of your card). Ask specifically whether your diagnosis qualifies for treatment coverage and what documentation is required. In most states, you will need a Service Authorization Request submitted by your provider, along with supporting documentation like clinic visit notes, a dermatologist’s diagnosis, and evidence of medical necessity. Requests submitted without this documentation are typically sent back for more information, which delays the process.
If your plan denies coverage, you have the right to appeal. A dermatologist’s letter explaining the medical impact of your condition, including any documented psychological effects like anxiety or depression, can strengthen an appeal. Some states also have patient advocacy organizations that help Medicaid enrollees navigate the appeals process for denied claims.